Precigen Reported $53.1 Million Revenue for Papzimeos
The Germantown firm saw its immunotherapy drug for rare respiratory conditions generate significant sales in Q2 2026.
Live Poll
Should local governments prioritize investments to attract and expand the biotech industry in your area?